Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Wendy Chao; Carlos Belmonte; José M. Benitez del Castillo; Anthony J. Bron; Harminder S. Dua; Kelly K. Nichols; Gary D. Novack; Stefan Schrader; Mark D. Willcox; James S. Wolffsohn; David A. Sullivan

doi:10.1016/j.jtos.2015.11.003

Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Wendy Chao, Carlos Belmonte, José M. Benitez del Castillo, Anthony J. Bron, Harminder S. Dua, Kelly K. Nichols, Gary D. Novack, Stefan Schrader, Mark D. Willcox, James S. Wolffsohn, David A. Sullivan^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

In March 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i2 = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i2 meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i2 meeting.

Original language	English
Pages (from-to)	264-316
Journal	Ocular Surface
Volume	14
Issue number	2
Early online date	14 Jan 2016
DOIs	https://doi.org/10.1016/j.jtos.2015.11.003 https://doi.org/10.1016/j.jtos.2015.11.003
Publication status	Published - 1 Apr 2016

Bibliographical note

Keywords

clinical trials
drug development
dry eye disease (DED)
Dry Eye WorkShop II (DEWS II)
i = initiating innovation series
Tear Film & Ocular Surface Society

Access to Document

Inaugural Meeting of the TFOS i2
© 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Accepted author manuscript, 1.75 MBLicence: CC BY-NC-ND 3.0
Report of the Inaugural Meeting of the TFOS
© 2016, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Accepted author manuscript, 2.55 MBLicence: CC BY-NC-ND 3.0

Cite this

Chao, W., Belmonte, C., del Castillo, J. M. B., Bron, A. J., Dua, H. S., Nichols, K. K., Novack, G. D., Schrader, S., Willcox, M. D., Wolffsohn, J. S., & Sullivan, D. A. (2016). Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment. Ocular Surface, 14(2), 264-316. https://doi.org/10.1016/j.jtos.2015.11.003, https://doi.org/10.1016/j.jtos.2015.11.003

@article{6091763c9af44902bb3606999f1335ab,

title = "Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment",

abstract = "In March 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i2 = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Domp{\'e}. The TFOS i2 meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i2 meeting.",

keywords = "clinical trials, drug development, dry eye disease (DED), Dry Eye WorkShop II (DEWS II), i = initiating innovation series, Tear Film & Ocular Surface Society",

author = "Wendy Chao and Carlos Belmonte and {del Castillo}, {Jos{\'e} M. Benitez} and Bron, {Anthony J.} and Dua, {Harminder S.} and Nichols, {Kelly K.} and Novack, {Gary D.} and Stefan Schrader and Willcox, {Mark D.} and Wolffsohn, {James S.} and Sullivan, {David A.}",

note = "{\textcopyright} 2016, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ ",

year = "2016",

month = apr,

day = "1",

doi = "10.1016/j.jtos.2015.11.003",

language = "English",

volume = "14",

pages = "264--316",

journal = "Ocular Surface",

issn = "1542-0124",

publisher = "Ethis Communications, Inc.",

number = "2",

}

Chao, W, Belmonte, C, del Castillo, JMB, Bron, AJ, Dua, HS, Nichols, KK, Novack, GD, Schrader, S, Willcox, MD, Wolffsohn, JS & Sullivan, DA 2016, 'Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment', Ocular Surface, vol. 14, no. 2, pp. 264-316. https://doi.org/10.1016/j.jtos.2015.11.003, https://doi.org/10.1016/j.jtos.2015.11.003

TY - JOUR

T1 - Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

AU - Chao, Wendy

AU - Belmonte, Carlos

AU - del Castillo, José M. Benitez

AU - Bron, Anthony J.

AU - Dua, Harminder S.

AU - Nichols, Kelly K.

AU - Novack, Gary D.

AU - Schrader, Stefan

AU - Willcox, Mark D.

AU - Wolffsohn, James S.

AU - Sullivan, David A.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - In March 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i2 = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i2 meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i2 meeting.

AB - In March 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i2 = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i2 meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i2 meeting.

KW - clinical trials

KW - drug development

KW - dry eye disease (DED)

KW - Dry Eye WorkShop II (DEWS II)

KW - i = initiating innovation series

KW - Tear Film & Ocular Surface Society

UR - http://www.scopus.com/inward/record.url?scp=84963946846&partnerID=8YFLogxK

U2 - 10.1016/j.jtos.2015.11.003

DO - 10.1016/j.jtos.2015.11.003

M3 - Article

C2 - 26774910

SN - 1542-0124

VL - 14

SP - 264

EP - 316

JO - Ocular Surface

JF - Ocular Surface

IS - 2

ER -